Trogenix
PrivateLast Round
Series A
Oct 6, 2025
Total Funding Raised
$133.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Trogenix is a biotechnology company that develops precision cancer treatments using its proprietary Odysseus® genetic medicine platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trogenix Comparables
Compare Trogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siren Biotechnology | 79% | |
| Chromatin Bioscience | 79% | |
| SynGenSys | 77% | |
Trogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2025 | ||||
| Seed | Nov 18, 2024 |
Key People
Founding team and executive leadership
Trogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4BIO Capital | Series A, Seed |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| LongeVC | Series A |
| Old College Capital | Seed |
| Calculus Capital | Series A |
| Cancer Research Horizons | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 17% QoQ, from 18 to 21 employees.
- May 17, 2026
Grew 18% QoQ, from 17 to 20 employees.
Trogenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trogenix's valuation, stock price, and market status.